ClinicalTrials.gov record
Long Term Open Label Continuation Study
ClinicalTrials.gov ID: NCT00195650
Public ClinicalTrials.gov record NCT00195650. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center Continuation Study of the Human Anti-TNF Antibody D2E7 Administered as a Subcutaneous Injection in Patients With Rheumatoid Arthritis
Study identification
- NCT ID
- NCT00195650
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Abbott
- Industry
- Enrollment
- 846 participants
Conditions and interventions
Conditions
Interventions
- Adalimumab Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2000
- Primary completion
- Apr 30, 2011
- Completion
- Apr 30, 2011
- Last update posted
- Aug 30, 2012
2000 – 2011
United States locations
- U.S. sites
- 74
- U.S. states
- 30
- U.S. cities
- 69
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 538 | Birmingham | Alabama | 35205 | — |
| Site Reference ID/Investigator# 4111 | Birmingham | Alabama | 35294-7201 | — |
| Site Reference ID/Investigator# 4113 | Mobile | Alabama | 36608 | — |
| Site Reference ID/Investigator# 408 | Anchorage | Alaska | 99508 | — |
| Site Reference ID/Investigator# 537 | Tucson | Arizona | 85710 | — |
| Site Reference ID/Investigator# 66822 | Anaheim | California | 92801 | — |
| Site Reference ID/Investigator# 557 | La Jolla | California | 92037-0943 | — |
| Site Reference ID/Investigator# 387 | Los Angeles | California | 90048 | — |
| Site Reference ID/Investigator# 555 | Los Angeles | California | 90095 | — |
| Site Reference ID/Investigator# 552 | Santa Barbara | California | 93105 | — |
| Site Reference ID/Investigator# 66864 | Santa Monica | California | 90404 | — |
| Site Reference ID/Investigator# 535 | Stanford | California | 94305 | — |
| Site Reference ID/Investigator# 3412 | Upland | California | 91786 | — |
| Site Reference ID/Investigator# 451 | Westlake Village | California | 91361 | — |
| Site Reference ID/Investigator# 572 | Colorado Springs | Colorado | 80910 | — |
| Site Reference ID/Investigator# 4109 | Denver | Colorado | 80230 | — |
| Site Reference ID/Investigator# 541 | Danbury | Connecticut | 06810 | — |
| Site Reference ID/Investigator# 654 | Milford | Connecticut | 06460 | — |
| Site Reference ID/Investigator# 655 | Wilmington | Delaware | 19808 | — |
| Site Reference ID/Investigator# 455 | Daytona Beach | Florida | 32114 | — |
| Site Reference ID/Investigator# 431 | Fort Lauderdale | Florida | 33334 | — |
| Site Reference ID/Investigator# 574 | Fort Myers | Florida | 33901 | — |
| Site Reference ID/Investigator# 66843 | Gainesville | Florida | 32605 | — |
| Site Reference ID/Investigator# 579 | Orlando | Florida | 32804 | — |
| Site Reference ID/Investigator# 571 | Palm Harbor | Florida | 34684 | — |
| Site Reference ID/Investigator# 651 | Sarasota | Florida | 34239 | — |
| Site Reference ID/Investigator# 66863 | St. Petersburg | Florida | 33710 | — |
| Site Reference ID/Investigator# 542 | Tampa | Florida | 33609 | — |
| Site Reference ID/Investigator# 415 | Vero Beach | Florida | 32962 | — |
| Site Reference ID/Investigator# 652 | Zephyrhills | Florida | 33542 | — |
| Site Reference ID/Investigator# 449 | Boise | Idaho | 83702 | — |
| Site Reference ID/Investigator# 4110 | Boise | Idaho | 83706 | — |
| Site Reference ID/Investigator# 650 | Coeur d'Alene | Idaho | 83814 | — |
| Site Reference ID/Investigator# 578 | Chicago | Illinois | 60612 | — |
| Site Reference ID/Investigator# 4112 | Indianapolis | Indiana | 46260 | — |
| Site Reference ID/Investigator# 547 | Louisville | Kentucky | 40291 | — |
| Site Reference ID/Investigator# 534 | Metairie | Louisiana | 70006 | — |
| Site Reference ID/Investigator# 544 | Chevy Chase | Maryland | 20815 | — |
| Site Reference ID/Investigator# 653 | Boston | Massachusetts | 02115 | — |
| Site Reference ID/Investigator# 4114 | Worcester | Massachusetts | 01610 | — |
| Site Reference ID/Investigator# 546 | Petoskey | Michigan | 49770 | — |
| Site Reference ID/Investigator# 577 | St Louis | Missouri | 63128 | — |
| Site Reference ID/Investigator# 549 | Billings | Montana | 59101 | — |
| Site Reference ID/Investigator# 561 | Reno | Nevada | 89502 | — |
| Site Reference ID/Investigator# 573 | Dover | New Jersey | 07801 | — |
| Site Reference ID/Investigator# 66842 | Toms River | New Jersey | 08755 | — |
| Site Reference ID/Investigator# 559 | Voorhees Township | New Jersey | 08043 | — |
| Site Reference ID/Investigator# 562 | Albuquerque | New Mexico | 87102 | — |
| Site Reference ID/Investigator# 66823 | Brooklyn | New York | 11203 | — |
| Site Reference ID/Investigator# 432 | Lake Success | New York | 11042 | — |
| Site Reference ID/Investigator# 657 | New York | New York | 10003 | — |
| Site Reference ID/Investigator# 647 | New York | New York | 10021 | — |
| Site Reference ID/Investigator# 545 | Port Jefferson Station | New York | 11776 | — |
| Site Reference ID/Investigator# 540 | Syracuse | New York | 13210 | — |
| Site Reference ID/Investigator# 646 | Statesville | North Carolina | 28625 | — |
| Site Reference ID/Investigator# 438 | Cincinnati | Ohio | 45219 | — |
| Site Reference ID/Investigator# 436 | Dayton | Ohio | 45408 | — |
| Site Reference ID/Investigator# 548 | Bend | Oregon | 97701 | — |
| Site Reference ID/Investigator# 553 | Eugene | Oregon | 97401 | — |
| Site Reference ID/Investigator# 532 | Portland | Oregon | 97205 | — |
| Site Reference ID/Investigator# 570 | Bethlehem | Pennsylvania | 18015 | — |
| Site Reference ID/Investigator# 575 | Ridley Park | Pennsylvania | 19078-2210 | — |
| Site Reference ID/Investigator# 585 | Willow Grove | Pennsylvania | 19090 | — |
| Site Reference ID/Investigator# 2435 | Dallas | Texas | 75231 | — |
| Site Reference ID/Investigator# 536 | Richmond | Virginia | 23219 | — |
| Site Reference ID/Investigator# 649 | Everett | Washington | 98201 | — |
| Site Reference ID/Investigator# 66862 | Everett | Washington | 98201 | — |
| Site Reference ID/Investigator# 531 | Kirkland | Washington | 98034 | — |
| Site Reference ID/Investigator# 412 | Olympia | Washington | 98502 | — |
| Site Reference ID/Investigator# 658 | Spokane | Washington | 99204 | — |
| Site Reference ID/Investigator# 576 | Vancouver | Washington | 98664 | — |
| Site Reference ID/Investigator# 551 | Yakima | Washington | 98902 | — |
| Site Reference ID/Investigator# 656 | Glendale | Wisconsin | 53217 | — |
| Site Reference ID/Investigator# 539 | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00195650, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00195650 live on ClinicalTrials.gov.